Noradrenalină Kabi (Noradrenaline Tartrate)

Norepinephrine, the active ingredient in Noradrenalină Kabi, is a sympathomimetic (alpha‑adrenergic agonist) presented as an injectable solution for intravenous use. It treats acute hypotension and various shock states in hospitalized patients who require rapid circulatory support.

GNH USA supplies Noradrenalină Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Noradrenaline acts on the sympathetic cardiovascular pathway to restore blood pressure in critical care settings.

Acute hypotension: raises systemic blood pressure to maintain organ perfusion. Septic shock: supports vascular tone and cardiac output in sepsis‑related hypotension. Cardiogenic shock: improves myocardial contractility and systemic perfusion in heart‑failure‑related shock. Post‑operative hypotension: corrects low blood pressure after surgery.

Adverse reactions may vary with dose, infusion rate, and patient condition.

Common Side Effects: - Tachycardia: rapid heart rate due to β1 stimulation. - Hypertension: excessive rise in blood pressure from α1 vasoconstriction. - Arrhythmia: irregular cardiac rhythm, especially in susceptible patients. - Headache: vascular changes can trigger cranial discomfort. - Anxiety or restlessness: central sympathetic activation. - Nausea: gastrointestinal upset during infusion.

Serious or Rare Side Effects: - Myocardial ischemia: reduced coronary blood flow from severe vasoconstriction. - Severe hypertension: dangerous elevation of arterial pressure. - Tissue necrosis at infusion site: extravasation injury. - Pulmonary edema: fluid accumulation due to increased afterload. - Life‑threatening arrhythmias: ventricular tachycardia or fibrillation. - Cardiac arrest: profound circulatory collapse in extreme cases.

Careful monitoring and risk assessment are essential when using norepinephrine.

Blood pressure monitoring: continuous invasive measurement to titrate infusion. Cardiac monitoring: ECG surveillance for arrhythmias. Dose titration: adjust gradually to avoid abrupt hemodynamic shifts. Coronary artery disease: use with caution, as increased workload may precipitate ischemia. Uncontrolled hypertension: contraindicated; avoid rapid escalation. Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Norepinephrine may have additive or antagonistic effects with several drug classes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension. - Tricyclic antidepressants: potentiation of vasoconstrictive response. - Other potent vasopressors: can cause excessive vascular tone.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt β1‑mediated cardiac effects. - ACE inhibitors or ARBs: may enhance hypotensive episodes if norepinephrine is withdrawn. - Calcium channel blockers: possible additive effects on vascular resistance.